The MVK gene helps your body make cholesterol and other small molecules that support cell growth, energy use, and immune signaling. This gene plays an important role in keeping inflammation under control. When both copies do not work well, it can cause mevalonate kinase deficiency, which often brings repeated fever attacks, belly pain, swollen lymph nodes, rash, and joint pain. More severe variants can also affect growth and development.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, which are the functional parts of cells. Others mainly regulate when specific processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can read more in LearnHub.
Overview
MVKGene function
What if the gene works
The MVK gene gives cells instructions to make mevalonate kinase, an enzyme that helps turn mevalonic acid into substances your body uses to make cholesterol and other important cell building molecules.
Risk
What if the gene does not work
Changes in the MVK gene can cause mevalonate kinase deficiency, ranging from fever attacks with rash, belly pain, and pain in joints to a more severe form with developmental problems. Milder or more severe variants can affect onset and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the MVK gene can make IL-1 blocking treatment especially relevant. Medicines such as anakinra or canakinumab are established options to reduce flares and ongoing inflammation, and some people may benefit from TNF blocking treatment if IL-1 therapy does not help enough.
Conditions associated with MVK
Gene function
What if the gene works
Understanding MVK gene function helps explain how cells make important fats they use every day. The MVK gene helps process mevalonate, a natural substance your body turns into cholesterol and other small cell building blocks. These products support cell membranes and help many proteins work in the right place.
The MVK gene helps convert mevalonate into the next usable step in an important cell pathway. This step uses energy from ATP, the cell's energy source, so the pathway can keep moving.
By supporting this pathway, the MVK gene helps your body make cholesterol. Cholesterol is a normal part of cell membranes and gives cells some of the material they need for everyday structure.
The same pathway also makes small molecules that act like tags for certain proteins. These tags help some proteins attach to cell membranes, where they can send signals and carry out their tasks.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MVK gene can change the enzyme’s shape, stability, or amount, which lowers how well it works inside cells. In plain terms, how variants in the MVK gene affect enzyme activity depends on the change: milder variants often leave some activity, while more severe variants can leave very little or none. That functional gap can influence whether mevalonate kinase deficiency appears later with recurring flares or starts earlier with broader features.
How variants are linked to conditions
Pathogenic variants in the MVK gene cause mevalonate kinase deficiency, a condition spectrum that includes a recurrent fever syndrome historically called hyper-IgD syndrome and a more severe form called mevalonic aciduria. When people read about MVK gene variants linked to recurrent fever syndrome, this is usually the association being described. Severity varies widely, from repeated inflammatory episodes to more persistent health and developmental problems.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with disease-causing changes in the MVK gene, risk is mostly set by the gene change itself. Flares can often be triggered by infections, vaccinations, physical or emotional stress, surgery, or menstrual periods. Avoiding known triggers when possible and having regular medical follow-up can help lower the chance of complications.
Inheritance of MVK variants
The inheritance pattern for MVK-related conditions depends on the condition. Mevalonate kinase deficiency is usually inherited in an autosomal recessive way, meaning a child receives one MVK variant from each parent; parents who each carry one variant are often unaffected, and each pregnancy has a 25% chance of the child being affected. Some skin conditions linked to the MVK gene, including certain forms of porokeratosis, follow an autosomal dominant pattern, so a parent carrying the variant can pass it to a son or daughter with a 50% chance.
What does my MVK result mean for my family?
For family members, the meaning of an MVK result depends on which MVK-related condition it is tied to. For the inflammatory condition linked to MVK, this usually means parents, brothers, sisters, and children may want to learn whether they carry the same gene change, especially if there is a family history of similar symptoms. MVK has also been linked to a separate skin condition that can run in families in a dominant pattern, so the family impact can differ by result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the MVK gene, doctors use genetic testing for MVK variants, usually on a blood sample or cheek swab. A lab reads the DNA code in the MVK gene and checks for variants that may help explain symptoms or confirm a suspected inherited condition.
When should I consider getting a genetic test?
Consider MVK genetic testing if there are repeated unexplained fever attacks, often starting in infancy or childhood, especially with swollen glands, belly pain, diarrhea, joint pain, or a rash. Testing can also help when a close relative has mevalonate kinase deficiency or a known MVK variant.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it explains depends on the condition and the type of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes can affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MVK gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about treatment, side effects, or new symptoms are best discussed with your doctor.
History
In the 1980s, doctors described two puzzling inherited fever conditions: mevalonic aciduria and, soon after, hyper-IgD syndrome with recurrent fever. Researchers later recognized that these conditions were closely related rather than completely separate illnesses. In 1999, studies showed that variants in the MVK gene were the shared cause, linking people with very different symptom patterns. From these first observations, research expanded steadily. This discovery helped move care for some periodic fever conditions from symptom-based labels toward gene-based diagnosis, clearer family counseling, and a better understanding of why severity can vary so much from one person to another.